These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24623196)

  • 1. Experimental evidence for protein oxidative damage and altered antioxidant defense in patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Derks TG; Touw CM; Ribas GS; Biancini GB; Vanzin CS; Negretto G; Mescka CP; Reijngoud DJ; Smit GP; Wajner M; Vargas CR
    J Inherit Metab Dis; 2014 Sep; 37(5):783-9. PubMed ID: 24623196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased antioxidant response in medium-chain acyl-CoA dehydrogenase deficiency: does lipoic acid have a protective role?
    Nochi Z; Birkler RID; Fernandez-Guerra P; Hansen J; Wibrand F; Corydon TJ; Gregersen N; Olsen RKJ
    Pediatr Res; 2020 Oct; 88(4):556-564. PubMed ID: 32045933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biochemical outcomes of patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Anderson DR; Viau K; Botto LD; Pasquali M; Longo N
    Mol Genet Metab; 2020 Jan; 129(1):13-19. PubMed ID: 31836396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nationwide retrospective observational study of population newborn screening for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in the Netherlands.
    Jager EA; Kuijpers MM; Bosch AM; Mulder MF; Gozalbo ER; Visser G; de Vries M; Williams M; Waterham HR; van Spronsen FJ; Schielen PCJI; Derks TGJ
    J Inherit Metab Dis; 2019 Sep; 42(5):890-897. PubMed ID: 31012112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders.
    Ribas GS; Vargas CR; Wajner M
    Gene; 2014 Jan; 533(2):469-76. PubMed ID: 24148561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method.
    Schmidt-Sommerfeld E; Penn D; Rinaldo P; Kossak D; Li BU; Huang ZH; Gage DA
    Pediatr Res; 1992 Jun; 31(6):545-51. PubMed ID: 1635814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with medium-chain acyl-coenzyme a dehydrogenase deficiency have impaired oxidation of fat during exercise but no effect of L-carnitine supplementation.
    Madsen KL; Preisler N; Orngreen MC; Andersen SP; Olesen JH; Lund AM; Vissing J
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1667-75. PubMed ID: 23426616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vulnerability to oxidative stress in vitro in pathophysiology of mitochondrial short-chain acyl-CoA dehydrogenase deficiency: response to antioxidants.
    Zolkipli Z; Pedersen CB; Lamhonwah AM; Gregersen N; Tein I
    PLoS One; 2011 Apr; 6(4):e17534. PubMed ID: 21483766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification by residual enzyme activity after newborn screening for medium-chain acyl-CoA dehyrogenase deficiency: data from a cohort study.
    Touw CM; Smit GP; de Vries M; de Klerk JB; Bosch AM; Visser G; Mulder MF; Rubio-Gozalbo ME; Elvers B; Niezen-Koning KE; Wanders RJ; Waterham HR; Reijngoud DJ; Derks TG
    Orphanet J Rare Dis; 2012 May; 7():30. PubMed ID: 22630369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
    Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM
    Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living on the edge: substrate competition explains loss of robustness in mitochondrial fatty-acid oxidation disorders.
    van Eunen K; Volker-Touw CM; Gerding A; Bleeker A; Wolters JC; van Rijt WJ; Martines AM; Niezen-Koning KE; Heiner RM; Permentier H; Groen AK; Reijngoud DJ; Derks TG; Bakker BM
    BMC Biol; 2016 Dec; 14(1):107. PubMed ID: 27927213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-carnitine and exercise tolerance in medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency: a pilot study.
    Lee PJ; Harrison EL; Jones MG; Jones S; Leonard JV; Chalmers RA
    J Inherit Metab Dis; 2005; 28(2):141-52. PubMed ID: 15877203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medium-chain acyl-CoA dehydrogenase deficiency: metabolic effects and therapeutic efficacy of long-term L-carnitine supplementation.
    Treem WR; Stanley CA; Goodman SI
    J Inherit Metab Dis; 1989; 12(2):112-9. PubMed ID: 2502671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium-chain fatty acids accumulating in MCAD deficiency elicit lipid and protein oxidative damage and decrease non-enzymatic antioxidant defenses in rat brain.
    Schuck PF; Ferreira GC; Moura AP; Busanello EN; Tonin AM; Dutra-Filho CS; Wajner M
    Neurochem Int; 2009 Jul; 54(8):519-25. PubMed ID: 19428797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of plasma ghrelin in patients with medium-chain acyl-CoA dehydrogenase deficiency and glutaric aciduria type II.
    Akamizu T; Sakura N; Shigematsu Y; Tajima G; Ohtake A; Hosoda H; Iwakura H; Ariyasu H; Kangawa K
    Eur J Endocrinol; 2012 Feb; 166(2):235-40. PubMed ID: 22048973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood.
    Van Hove JL; Zhang W; Kahler SG; Roe CR; Chen YT; Terada N; Chace DH; Iafolla AK; Ding JH; Millington DS
    Am J Hum Genet; 1993 May; 52(5):958-66. PubMed ID: 8488845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resuscitation of a neonate with medium chain acyl-coenzyme a dehydrogenase deficiency using extracorporeal life support.
    Kumar G; Mattke AC; Bowling F; McWhinney A; Alphonso N; Karl TR
    World J Pediatr Congenit Heart Surg; 2014 Jan; 5(1):118-20. PubMed ID: 24403369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry.
    Clayton PT; Doig M; Ghafari S; Meaney C; Taylor C; Leonard JV; Morris M; Johnson AW
    Arch Dis Child; 1998 Aug; 79(2):109-15. PubMed ID: 9797589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of redox homeostasis in cerebral cortex of developing rats by acylcarnitines accumulating in medium-chain acyl-CoA dehydrogenase deficiency.
    Tonin AM; Grings M; Knebel LA; Zanatta Â; Moura AP; Ribeiro CA; Leipnitz G; Wajner M
    Int J Dev Neurosci; 2012 Aug; 30(5):383-90. PubMed ID: 22472139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalization of short-chain acylcoenzyme A dehydrogenase after riboflavin treatment in a girl with multiple acylcoenzyme A dehydrogenase-deficient myopathy.
    DiDonato S; Gellera C; Peluchetti D; Uziel G; Antonelli A; Lus G; Rimoldi M
    Ann Neurol; 1989 May; 25(5):479-84. PubMed ID: 2774489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.